Trademark: 97690355
Status Date
Tuesday, March 12, 2024
Filing Date
Wednesday, November 23, 2022
Published for Opposition
Tuesday, July 25, 2023
5 Pharmaceutical preparations for human use for the treatment and prevention of cancer, auto-immune diseases, leukemia, lymphoma, multiple myeloma, autoinflammatory disease and tumors; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer and cytokine inhibitory drugs; pharmaceutical and biological preparations for human use for immunotherapy, namely, T cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use, all the foregoing excluding pharmaceutical preparations for the treatment of hemophilia
Mar 12, 2024
Noa E-Mailed - Sou Required From Applicant
Feb 1, 2024
Extension Of Time To Oppose Process - Terminated
Dec 30, 2023
Changes/Corrections After Pub Approval Entered
Dec 26, 2023
Assigned To Petition Staff
Nov 17, 2023
Teas Post Publication Amendment Received
Aug 18, 2023
Extension Of Time To Oppose Received
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Owner Address Received
Jul 25, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2023
Published For Opposition
Jul 5, 2023
Notification Of Notice Of Publication E-Mailed
Jun 20, 2023
Approved For Pub - Principal Register
Jun 14, 2023
Teas/Email Correspondence Entered
Jun 14, 2023
Correspondence Received In Law Office
Jun 14, 2023
Teas Response To Office Action Received
Mar 16, 2023
Notification Of Non-Final Action E-Mailed
Mar 16, 2023
Non-Final Action E-Mailed
Mar 16, 2023
Non-Final Action Written
Mar 8, 2023
Assigned To Examiner
Nov 28, 2022
New Application Office Supplied Data Entered
Nov 26, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
